Roberto Gerli

820 total citations
7 papers, 454 citations indexed

About

Roberto Gerli is a scholar working on Rheumatology, Genetics and Hepatology. According to data from OpenAlex, Roberto Gerli has authored 7 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 4 papers in Genetics and 2 papers in Hepatology. Recurrent topics in Roberto Gerli's work include Systemic Lupus Erythematosus Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Roberto Gerli is often cited by papers focused on Systemic Lupus Erythematosus Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Roberto Gerli collaborates with scholars based in Italy, United Kingdom and France. Roberto Gerli's co-authors include A.M. Liberati, E Marzo, Fabrizio Lombardini, G. Longombardo, Cássia Ferri, A. Moretti, L La Civita, F. Greco, Renato Vanacore and Claudio Lunardi and has published in prestigious journals such as Blood, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

Roberto Gerli

7 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto Gerli Italy	6	234	178	115	113	109	7	454
Francesco Saccardo Italy	13	254 1.1×	407 2.3×	228 2.0×	72 0.6×	156 1.4×	20	631
Z. Amoura France	9	274 1.2×	50 0.3×	76 0.7×	136 1.2×	29 0.3×	22	480
Pier Vittorio Fosella Italy	6	127 0.5×	214 1.2×	117 1.0×	54 0.5×	68 0.6×	6	410
Marlène Garrido France	10	249 1.1×	97 0.5×	92 0.8×	257 2.3×	63 0.6×	12	670
Elisa Fognani Italy	13	239 1.0×	505 2.8×	286 2.5×	56 0.5×	120 1.1×	19	659
L Casatta Italy	10	186 0.8×	41 0.2×	45 0.4×	90 0.8×	88 0.8×	12	379
C. Fellbaum Germany	10	52 0.2×	122 0.7×	102 0.9×	74 0.7×	37 0.3×	19	503
Kayoko Murayama Japan	12	70 0.3×	76 0.4×	70 0.6×	31 0.3×	133 1.2×	39	489
Naoya Sekiguchi Japan	15	523 2.2×	30 0.2×	223 1.9×	110 1.0×	142 1.3×	29	685

Countries citing papers authored by Roberto Gerli

Since Specialization

Citations

This map shows the geographic impact of Roberto Gerli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Gerli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Gerli more than expected).

Fields of papers citing papers by Roberto Gerli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Gerli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Gerli. The network helps show where Roberto Gerli may publish in the future.

Co-authorship network of co-authors of Roberto Gerli

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Gerli. A scholar is included among the top collaborators of Roberto Gerli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Gerli. Roberto Gerli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Fraticelli, Paolo, Giovanni Pomponio, Gabriele Valentini, et al.. (2014). Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study. Arthritis Research & Therapy. 16(4). R144–R144. 82 indexed citations

2.

Iannone, Florenzo, Elisa Gremese, Fabiola Atzeni, et al.. (2012). Longterm Retention of Tumor Necrosis Factor-α Inhibitor Therapy in a Large Italian Cohort of Patients with Rheumatoid Arthritis from the GISEA Registry: An Appraisal of Predictors. The Journal of Rheumatology. 39(6). 1179–1184. 76 indexed citations

3.

Bartoloni, Elena, et al.. (2011). Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations. Reumatismo. 61(1). 48–53. 5 indexed citations

4.

Cimmino, Marco A., Carlo Salvarani, P. Macchioni, et al.. (2008). Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids.. PubMed. 26(3). 395–400. 48 indexed citations

5.

Gerli, Roberto, Onelia Bistoni, Claudio Lunardi, et al.. (1999). Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy. Lara D. Veeken. 38(12). 1282–1284. 23 indexed citations

6.

Ferri, Cássia, E Marzo, G. Longombardo, et al.. (1993). Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood. 81(5). 1132–1136. 215 indexed citations

7.

Ferri, Cássia, E Marzo, G. Longombardo, et al.. (1993). Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood. 81(5). 1132–1136. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact